Citigroup Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $35
Leerink Partners Initiates Coverage On Seaport Therapeutics with Outperform Rating, Announces Price Target of $35
JP Morgan Initiates Coverage On Seaport Therapeutics with Overweight Rating, Announces Price Target of $42
Stifel Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $30
Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move
Seaport Therapeutics IPO Indicating $25/Share On 670K Shares; IPO Priced At $18/Share On 14.16M Shares
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
Seaport Therapeutics Pursues IPO On Positive Trial Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
